Michael Green, neuroscientist and professor of psychiatry and biobehavioral sciences at UCLA, has been fascinated with the human brain, behavior and mental illness since his undergraduate days. In particular, his research focuses on schizophrenia, a chronic brain disorder that affects about 1 percent of the population.
In this UCLA Faculty Research Lecture, he describes how his lab uses discoveries in psychology and social neuroscience about normal brain functioning to inform his schizophrenia research. And now, Green and his colleagues are moving into new territory, studying the causes of social isolation among people who do not have schizophrenia.
You’ll learn about the tools they use such as functional MRI, that measures and maps brain activity, and EEG, that detects electrical activity in the brain, and how they do research to answer questions about social isolation in the general public.
Continuing our in-depth look at Alzheimer’s disease, On Our Mind examines the patient experience as well as the impact of the disease on families and communities. Learn more with our newest installments:
The Brain Channel’s flagship series On Our Mind takes a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.
An estimated 5 million Americans have Alzheimer’s disease and that number will continue to rise. The impact will be felt not just in the homes of the diagnosed but by their caregivers, their loved ones, their communities, and beyond.
The Brain Channel’s flagship series On Our Mind is endeavoring in the next few months to take a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.
Agenda: Alzheimer’s Disease Cure and Care
There are more than 5 million Americans living with Alzheimer’s disease. San Diego County Supervisor Dianne Jacob joins William Mobley, MD, PhD to discuss how we can better manage this disease from a public policy standpoint.
Stem Cells and Alzheimer’s Disease
Can stem cells be a weapon in the fight against Alzheimer’s disease? Larry Goldstein, PhD director the the UC San Diego Stem Cell Program, joins William Mobley, MD, PhD to discuss how stem cells work and what possibilities they may unlock.
The Anatomy of Memory
How do we create and store memories? Larry Squire PhD joins William Mobley MD, PhD to dissect these processes and how we might use this knowledge to aid in the fight against Alzheimer’s disease.
The Role of Synapses in Memory
Roberto Malinow, MD, PhD joins William Mobley MD, PhD to discuss his recent study where memories were not only erased but restored in rats. Learn how findings of this study could lead to breakthroughs in the treatment of Alzheimer’s disease.
Stay tuned to the Brain Channel for new installments in this informative series.
Dementia is a deterioration of cognitive function that begins with mild cognitive impairment, which appears just like forgetfulness, and eventually ends in death.
There are many causes of the disease such as stroke, chronic alcohol abuse and Alzheimer’s but there is no way to reverse the damage of the brain’s degeneration.
Dr. Mario D. Garrett of San Diego State University’s School of Social Work discusses the social impacts of dementia, such as the way dementia is classified by institutions and even the errors he has found in the way dementia is perceived.
There’s plenty that goes on in these heads of ours — sometimes more than we want or understand. But just how much does the way our minds work distinguish us from other species?
In the latest series from UC San Diego’s CARTA, scientists from different fields discuss the cognitive abilities that are often regarded as unique to humans, including humor, morality, symbolism, creativity and preoccupation with the minds of others. They assess the functional uniqueness of these attributes, as opposed to the anatomical uniqueness, and whether they are indeed quantitatively or qualitatively unique to humans.